A Focus

2 months ago | outsourcedpharma.com | Louis Garguilo |Jessica Carmen |A Focus |GC Cell

Webinar: Who’s In Charge of Your Trial? How to Ensure Effective Oversight and LeadershipClinical trials in complex therapeutic areas require more than just a solid strategy—they demand proactive and engaged operational leadership from the sponsor side. Join our expert panel to discuss how an active and knowledgeable Clin Ops lead, in collaboration with an experienced outsourcing project lead, can drive informed decision-making, enhance efficiency, and ultimately ensure trial success.

Jan 14, 2025 | outsourcedpharma.com | Louis Garguilo |Jessica Carmen |A Focus |I Outsource

We’re ready to help usher your next drug into market! 2025’s first Outsourced Pharma Capacity Update provides a unique, virtual experience and the details necessary to find a CDMO for your specific timeline, volume, and production needs. Join us the last week of January as we draw the curtains on the industry’s best and give you complimentary VIP access to the resources available to support your success.

Jan 10, 2025 | theautopian.com | Jason Torchinsky |A Benz |A Focus

Yesterday afternoon I took a break from writing to do some work on our member perks, like birthday car drawings and the thing that was taking the most time, making graphics for our new randomized member perk. You see, for renewing members, instead of getting another car drawing, I’ve been hand-making graphics on an old Apple II computer from the 1980s and writing BASIC programs to generate randomized, unique images. Last year we did robots; this year, we’re making cars.

Nov 12, 2024 | outsourcedpharma.com | Louis Garguilo |Drew N. Kelner |Andreas M. Beckhaus |A Focus

Put Your AAV On The Fast-Track To The ClinicAdvancements in molecular biology and viral therapy over the last 30 years have enabled rapid progression in the gene therapy space. Viral vectors, most notably lentiviruses, adenoviruses, and adeno-associated viruses (AAVs), are regularly used as gene delivery vehicles in gene and cell therapies. To meet the increasing demand for AAV gene therapies, developers and manufacturers must successfully navigate the challenges of AAV production. Learn more now.

Oct 8, 2024 | outsourcedpharma.com | Louis Garguilo |Raul P. Lima |inSeption Group |A Focus

Your Trusted Biologics Testing PartnerSGS Supports biopharmaceutical clients from discovery to clinical development and commercialization, through a comprehensive scope of expert-led quality control testing for raw materials, APIs, and finished products.